Arabic Arabic English English French French German German
dark

Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer’s patients

Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer’s disease, a new study finds. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tiziana Life Sciences Announces Death of Director

Next Post

Achilles Therapeutics Provides Business Update and Outlook for 2022

Related Posts
Total
0
Share